Warner Chilcott (WCRX) Sells Rights to Psoriasis Treatments to LEO Pharma for $1B
Tweet Send to a Friend
Warner Chilcott plc (Nasdaq: WCRX) announced this morning that LEO Pharma is re-acquiring ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


